Michael Giuliani
Director/Board Member at MIMEDX GROUP, INC.
Net worth: 812 624 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Hulse | M | 50 | 5 years | |
| Mark Tyndall | M | 48 | 10 years | |
| K. Newton | M | 61 | 5 years | |
| Douglas Rice | M | 58 | 1 years | |
| Scott M. Turner | M | 58 | 8 years | |
| Daniel J. Speciale | M | - | 11 years | |
| Phyllis Gardner | M | 73 | 3 years | |
| Cato Laurencin | M | 65 | - | |
| William Hawkins | M | 70 | 4 years | |
| Joe Capper | M | 60 | 1 years | |
| Martin Sutter | M | 68 | 4 years | |
| James Bierman | M | 71 | 5 years | |
| M. Wilsey | M | 71 | 5 years | |
| Rebeccah J. Covert Brown | M | - | 19 years | |
| David H. Mason | M | 77 | 10 years | |
| Ricci Whitlow | F | 55 | 1 years | |
| Mark P. Graves | M | 59 | 6 years | |
| Kate Surdez | F | - | 2 years | |
| Dirk Stevens | M | - | 3 years | |
| Matthew Notarianni | M | - | 2 years | |
| John R. Harper | M | - | 3 years | |
| Kim Moller | F | - | 4 years | |
| Eric Smith | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marion Snyder | F | - | 9 years | |
| Timothy Wright | M | 66 |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | 5 years |
| Mark Trudeau | M | 62 | 9 years | |
| Charles Robert Evans | M | 77 | 8 years | |
| Matthew Harbaugh | M | 53 | 6 years | |
| William A. Nuerge | M | 71 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | 3 years |
| Sandra L. Hatten | F | 67 | 5 years | |
| Angus Russell | M | 68 | 8 years | |
| Robert Stein | M | 73 | 3 years | |
| Neil S. Yeston | M | 81 | 8 years | |
| David Carlucci | M | 69 | 9 years | |
| Nancy Lurker | F | 66 | 3 years | |
| Diane Gulyas | F | 67 | 5 years | |
| Don Bailey | M | 78 | 2 years | |
| Peter Carlson | M | 60 | 4 years | |
| Joseph A. Zaccagnino | M | 77 | - | |
| Kneeland Youngblood | M | 69 | 9 years | |
| Melvin Booth | M | 79 | 5 years | |
| Virgil Thompson | M | 84 | - | |
| J. Carroll | M | 74 | 9 years | |
| Hugh M. Oneill | M | 60 | 9 years | |
| JoAnn Reed | F | 68 | 9 years | |
| Babatunde Otulana | M | 67 | 4 years | |
| Michael-Bryant Hicks | M | 49 | 2 years | |
| Marvin R. Haselhorst | M | - | - | |
| Jeffrey Patrick | M | 55 | 4 years | |
| Ronald Lloyd | M | 63 | 2 years | |
| Katherine Crewe | F | - | 7 years | |
| William Phelan | M | 53 | 5 years | |
| Dawn M. von Rohr | F | - | 21 years | |
| Raymond Furey | M | 56 | - | |
| Brian Elsbernd | M | 60 | 3 years | |
| Walter J. Kaczmarek | M | 65 | 4 years | |
| Karen Sheehy | F | 62 | - | |
| Barbara Bodem | F | 56 | 3 years | |
| Thomas Englese | M | 50 | 4 years | |
| Stan Micek | M | - | 3 years | |
| Matthew Mainer | M | 53 | 1 years | |
| Thomas E. Berry | M | 74 | - | |
| John J. Howarth | M | - | 2 years | |
| John E. Einwalter | M | 55 | - | |
| Barry C. Brandstetter | M | - |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | 4 years |
| Steven Romano | M | 64 | 7 years | |
| Craig Tooman | M | 58 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | - |
| Frank Scholz | M | 54 | 5 years | |
| Michael Mulroy | M | 58 | - | |
| Gregory D. Flexter | M | 68 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | - |
| Stephen Merrick | M | 63 | - | |
| Peter Edwards | M | 62 | 5 years | |
| Mario David Saltarelli | M | 63 | 2 years | |
| Steve Cartt | M | 61 | - | |
| Thomas J. Koob | M | 74 | 14 years | |
| Chuck Koob | M | 79 | 12 years | |
| David Keenan | M | - | - | |
| Thomas Smith | M | 63 | 2 years | |
| Rohit Kashyap | M | 53 | 3 years | |
| Gary Phillips | M | 58 | - | |
| Rolf Classon | M | 79 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 43 | 53.09% |
| United States | 38 | 46.91% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Giuliani
- Personal Network
